# Egalet Ltd clinical trials: 20 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 20 trials with Egalet Ltd as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Egalet Ltd: 20 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/egalet-ltd

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 20
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 20 newest of 20, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| March 23, 2016 | NCT02716857 | Efficacy and Safety of Egalet-002 in Patients With Moderate-to-Severe Chronic Low Back Pain | Egalet Ltd | Phase 3 | Completed | Moderate-to-severe Chronic Low Back Pain | 549 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02716857) |
| November 13, 2015 | NCT02603705 | Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain | Egalet Ltd | Phase 3 | Completed | Moderate-to-severe Chronic Noncancer Pain | 281 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02603705) |
| April 3, 2014 | NCT02102516 | SPRIX in 0 to 11 Year-Old Patients Undergoing Open Surgical Procedures | Egalet Ltd | Phase 3 | Completed | Pain | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02102516) |
| June 3, 2011 | NCT01365650 | Study to Assess the Absorption and Tolerability of Intranasal Ketorolac Tromethamine and to Assess the Effects of Oxymetazoline... | Egalet Ltd | Phase 1 | Completed | Allergic Rhinitis | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01365650) |
| June 3, 2011 | NCT01365611 | Open Label Study to Assess the Pharmacokinetics of Intranasal Ketorolac Tromethamine Following Fluticasone Propionate in Healthy Subjects | Egalet Ltd | Phase 1 | Completed | Healthy Subjects | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01365611) |
| June 1, 2011 | NCT01363089 | Study to Assess the PK of Ketorolac Tromethamine Intranasal and to Assess the Effects of a Oxymetazoline Hydrochloride on the PK of... | Egalet Ltd | Phase 1 | Completed | Assess Pharmacokinetics of Ketorolac Tromethamine Intranasal and Assess Effects of a Oxymetazoline Hydrochloride on the... | 21 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01363089) |
| June 1, 2011 | NCT01363076 | The Pharmacokinetics of Ketorolac Tromethamine Administered Intranasally (IN) for Postoperative Pain in Children Aged 12 Through 17 Years | Egalet Ltd | Phase 1 | Completed | Postoperative Pain | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01363076) |
| June 1, 2011 | NCT01363063 | Study of the Tolerability of Ketorolac Tromethamine Following Intranasal Administration in Healthy Volunteers | Egalet Ltd | Phase 1 | Completed | Healthy Volunteers | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01363063) |
| June 1, 2011 | NCT01363050 | Study to Determine the Tolerability, Safety and Pharmacokinetics of Ketorolac Tromethamine by Intranasal Administration in Healthy... | Egalet Ltd | Phase 1 | Completed | Healthy Volunteers | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01363050) |
| May 19, 2011 | NCT01356225 | A Single-dose Study of Intranasal Ketorolac in the Treatment of Pain Secondary to Dental Impaction Surgery | Egalet Ltd | Phase 2 | Completed | Pain, Dental Impaction | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01356225) |
| May 19, 2011 | NCT01356212 | Assessment of Nasal Deposition and Clearance of Ketorolac Solution Administered Using the Valois Nasal Spray Device | Egalet Ltd | Phase 1 | Completed | Healthy Subjects | 13 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01356212) |
| May 18, 2011 | NCT01355588 | Tolerability, Safety and Pharmacokinetics of Four Formulations of Ketorolac Tromethamine in Healthy Volunteers | Egalet Ltd | Phase 1 | Completed | Healthy Volunteers | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01355588) |
| May 4, 2011 | NCT01347853 | Safety and Efficacy of Multiple Doses of Ketorolac Tromethamine Administered Intranasally for Postoperative Pain | Egalet Ltd | Phase 3 | Completed | Postoperative Pain | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01347853) |
| December 4, 2008 | NCT00802308 | Effects of a Single Dose of Egalet® Morphine Combined With a Single Dose of Alcohol in Healthy Moderate Drinkers | Egalet Ltd | Phase 1 | Completed | Pain | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00802308) |
| December 4, 2008 | NCT00802087 | Single Dose Pharmacokinetics of Egalet® Hydrocodone | Egalet Ltd | Phase 1 | Completed | Pain | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00802087) |
| December 4, 2008 | NCT00801788 | Single Dose Pharmacokinetics of Egalet® Oxycodone | Egalet Ltd | Phase 1 | Completed | Pain | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00801788) |
| June 7, 2007 | NCT00483717 | Efficacy and Safety of Intranasal Ketorolac for the Acute Treatment of Migraine | Egalet Ltd | Phase 2 | Completed | Migraine | 173 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00483717) |
| March 12, 2007 | NCT00446069 | A Efficacy and Safety Trial of Controlled Release (CR) Morphine in Cancer Patients | Egalet Ltd | Phase 2 | Completed | Pain, Cancer | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00446069) |
| March 8, 2007 | NCT00444834 | A Study of Controlled-Release Carvedilol Compared to Immediate-Release Carvedilol in Patients With Primary Hypertension | Egalet Ltd | Phase 2 | Terminated | Hypertension | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00444834) |
| December 19, 2005 | NCT00266786 | Safety and Efficacy of Multiple Doses of Intranasal Ketorolac in Postoperative Pain Following Major Abdominal Surgery | Egalet Ltd | Phase 3 | Completed | Postoperative Pain | 321 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00266786) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 11 |
| Phase 2 | 4 |
| Phase 3 | 5 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 19 |
| Terminated | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Pain | 6 |
| Pain, Postoperative | 3 |
| Hypertension | 1 |
| Neoplasms | 1 |
| Migraine Disorders | 1 |
| Tooth, Impacted | 1 |
| Rhinitis, Allergic | 1 |
| Chronic Pain | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [B2B oil and gas extraction companies in the United States](https://specstream.ai/data/businesses/b2b-oil-and-gas-extraction-companies/united-states)
- [Manufacturers in the United States](https://specstream.ai/data/businesses/manufacturers/united-states)
- [B2B direct mail advertising companies in the United States](https://specstream.ai/data/businesses/b2b-direct-mail-advertising-companies/united-states)
- [Legal services firms in the United States](https://specstream.ai/data/businesses/legal-services-firms/united-states)
- [Assisted living facilities in the United States](https://specstream.ai/data/businesses/assisted-living-facilities/united-states)
- [Korean restaurants in the United States](https://specstream.ai/data/businesses/korean-restaurants/united-states)
